Revenue: The sum of all revenue fields included for a company's operating activities.
Organogenesis (ORGO) had Revenue of $99.65M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$99.65M |
$-0.57M |
|
$27.77M |
|
$71.88M |
|
$100.92M |
|
$-1.27M |
|
$-0.53M |
|
$-1.80M |
|
$-1.80M |
|
$-0.57M |
|
$-0.57M |
|
$-0.57M |
|
$-0.57M |
|
$-1.27M |
|
$5.06M |
|
131.23M |
|
132.75M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$225.04M |
|
$116.23M |
|
$234.98M |
|
$460.02M |
|
$80.51M |
|
$62.63M |
|
$100.85M |
|
$181.36M |
|
$278.66M |
|
$234.02M |
|
$278.66M |
|
131.32M |
|
| Cash Flow Statement Financials | |
$30.92M |
|
$-24.36M |
|
$-5.50M |
|
$103.29M |
|
$104.34M |
|
$1.05M |
|
$9.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
0.18 |
|
0.25 |
|
72.13% |
|
-1.27% |
|
-1.27% |
|
-- |
|
-1.80% |
|
-0.57% |
|
$6.55M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.98 |
|
1.22 |
|
74.06 |
|
-0.20% |
|
-0.24% |
|
-0.12% |
|
-0.17% |
|
$2.12 |
|
$0.05 |
|
$0.23 |
|